How Much Saffron Should I Take for Macular Degeneration?

Most clinical trials studying saffron for age-related macular degeneration (AMD) have used 20 milligrams per day of standardized saffron extract, taken as a single oral capsule. A smaller number of trials have tested 30 mg per day. Neither dose has been formally approved for AMD by any regulatory agency, but 20 mg daily is the figure that appears most consistently in the published research, and it is the dose with the longest follow-up data. The picture is more nuanced than a single number suggests, though, because how saffron performs depends on the type and stage of AMD, the form of saffron you take, and how long you take it.

The Dose Most Studied in Trials

The most commonly tested dose is 20 mg of saffron extract per day, given as a single capsule. A longitudinal study following patients with early AMD over an average of 14 months used exactly this amount, chosen because earlier pilot work had suggested it was enough to exert a protective effect on the retina.¹ A larger trial published in BMJ Open Ophthalmology also settled on 20 mg daily for the same reason.²

One placebo-controlled trial went higher, giving 60 patients with either wet or dry AMD a dose of 30 mg per day for six months.³ The researchers did not directly compare 20 mg against 30 mg, so we cannot say the higher dose works better. What we can say is that the range tested in human AMD studies sits between 20 and 30 mg daily. No published trial has gone above 30 mg for this condition, and there is no evidence that taking more produces a bigger benefit.

Why Saffron Might Help the Retina

Saffron’s potential eye benefits come mainly from two compounds: crocin and crocetin. These are carotenoid pigments responsible for saffron’s deep orange-red color, and they carry strong antioxidant and anti-inflammatory properties.⁴ In AMD, oxidative stress and chronic low-grade inflammation progressively damage the light-sensing photoreceptor cells and the tissue layer behind them. Crocin and crocetin appear to work against both of those processes.

Lab studies have shown that saffron extract can reduce photoreceptor cell death triggered by toxic calcium overload, essentially acting as a buffer that protects these cells when they are under stress.⁵ Separately, cell-culture work has found that crocin and crocetin can suppress the growth factor VEGF, which drives the abnormal blood vessel growth seen in wet AMD. In that lab setting, the anti-VEGF effect was comparable to bevacizumab, one of the injected drugs commonly used for wet AMD.⁶ That does not mean swallowing a capsule of saffron replaces an injection, but it does help explain the biological rationale researchers are working from.

What the Trials Actually Found

The most encouraging results come from the longitudinal study of early AMD patients taking 20 mg daily. After three months, participants showed an improvement in retinal electrical response (a measure of how well the photoreceptor cells are firing) and their visual acuity improved by about two lines on a standard eye chart. Those gains held steady across the entire follow-up period, which averaged 14 months.¹ A related study of 33 patients on the same dose confirmed a similar pattern: retinal function improved within three months and the improvement was maintained during follow-up.⁷

A separate study also found retinal function improvements at three months that stayed stable throughout a longer observation period.⁸ Worth noting, however, is that these early studies were small and did not always include a placebo comparison group, which makes the results harder to interpret with confidence. We are still talking about trials with a few dozen participants, not the kind of large-scale evidence that leads to clinical guidelines.

Results Differ Between Wet and Dry AMD

AMD comes in two forms, and the saffron data does not treat them identically. Dry AMD, which accounts for the large majority of cases, involves a slow breakdown of retinal cells. Wet AMD is less common but more aggressive, involving abnormal blood vessels that leak fluid beneath the retina. Most people diagnosed with AMD have the dry type.

The placebo-controlled trial that used 30 mg daily enrolled patients with both forms and tracked them for six months. For wet AMD, saffron produced a measurable reduction in macular thickness compared to placebo, which is a meaningful structural outcome. For dry AMD, that difference in macular thickness was not statistically significant. On the other hand, retinal electrical responses improved in dry AMD patients at three months, though those gains faded by six months. In wet AMD patients, retinal electrical responses also improved at three months but similarly did not hold at the six-month mark.⁹

The picture that emerges is mixed. Saffron may do slightly different things for wet and dry AMD, and the timing of the effects seems to vary. Researchers have pointed out that dry AMD, which progresses slowly, may need longer treatment periods to show clear benefits, while wet AMD might respond more quickly on structural measures like fluid reduction. But the honest assessment is that we do not yet have enough data to say definitively that one type responds better than the other.

How Long Before You Might Notice a Difference

The clinical data consistently points to three months as the earliest timeframe for measurable changes. In the longitudinal study using 20 mg daily, retinal function improvements appeared at the three-month mark and then remained stable for well over a year.¹ This suggests saffron is not a quick fix. If you start supplementing, expect to commit to at least a few months before having any basis for judging whether it is helping.

There is also a practical question about what happens when you stop. The same longitudinal study observed that the gains persisted as long as patients continued taking saffron, but the researchers noted that benefits could reverse when supplementation was discontinued. That aligns with how most nutritional supplements work: they influence ongoing biological processes rather than producing a permanent structural change. If saffron does help your retina, it likely needs to be taken continuously to maintain those benefits.

The Subjective Side of the Results

One intriguing finding from the placebo-controlled 30 mg trial was a disconnect between objective and subjective outcomes. On formal visual acuity testing, the researchers found no significant improvement in either the saffron group or the placebo group. Yet patients taking saffron frequently reported that their vision felt better, and they also described a greater sense of general wellbeing.¹⁰

The researchers speculated this may be partly explained by saffron’s known antidepressant properties. Depression is common among people with AMD, affecting roughly 30 percent of patients according to the study’s authors. If saffron lifts mood, that alone could change how someone experiences their vision and daily function, even without a measurable change on an eye chart. This is not a trivial finding. Quality of life matters, and a supplement that makes you feel genuinely better is not worthless just because it did not improve your reading of the smallest line on the chart. But it does mean you should be cautious about attributing perceived visual improvement to actual retinal changes.

Safety and Side Effects

At the doses used in eye research (20 to 30 mg daily), saffron has a good safety track record. A toxicology review concluded that therapeutic doses show no significant toxicity in either clinical or animal studies.¹¹ A systematic review of ocular studies specifically described saffron’s safety profile in eye conditions as “exceptional.”¹²

That said, saffron is not side-effect-free. A systematic review of adverse events across trials found that roughly 17.5 percent of participants experienced some kind of side effect. The most common were gastrointestinal complaints, and the review described them as minor and self-limiting in most cases. However, the review also cautioned that higher doses or prolonged use could potentially produce more serious effects, and recommended clinical monitoring.¹³

Very high doses of saffron (well above what any supplement provides, typically 5 grams or more at once) can be genuinely dangerous. At the 20 to 30 mg range used in AMD studies, you are nowhere near that threshold. Still, it is worth keeping your doctor informed about any supplement you take, especially if you are on other medications.

Saffron and Blood Pressure Medications

One interaction to be aware of involves blood pressure. A meta-analysis of randomized trials found that saffron supplementation produced a small but statistically significant drop in both systolic and diastolic blood pressure.¹⁴ The effect was modest, but if you are already taking blood pressure-lowering medication, even a small additional drop could matter. This is especially relevant for AMD patients, many of whom are older adults already managing cardiovascular conditions. Mention saffron to your prescribing physician so they can factor it in.

Saffron also has mild blood-thinning properties, which means it could theoretically amplify the effects of anticoagulant drugs. No clinical trial has flagged a serious bleeding event at the doses used for AMD, but the interaction is biologically plausible and worth discussing with your doctor if you are on blood thinners.

Standardized Extract vs. Cooking Saffron

Every clinical trial on saffron and AMD used a standardized extract in capsule form, not the saffron threads you buy at a grocery store. This distinction matters. Standardized extracts are manufactured to contain a known and consistent concentration of the active compounds crocin and crocetin. The saffron in your spice drawer can vary enormously in potency depending on its origin, age, storage conditions, and whether it has been adulterated (saffron fraud is common because the spice is so expensive).

Trying to replicate a 20 mg capsule by dissolving saffron threads in water or milk is unreliable for two reasons. First, you would not know how much crocin and crocetin you are actually consuming. Second, the total weight of saffron threads needed to deliver the same active compounds as a 20 mg extract depends entirely on the quality and processing of the extract and the threads, making a direct weight comparison misleading. If you want to try saffron supplementation for AMD, a standardized extract capsule is the only form that gives you a dose comparable to what was tested in the studies.

Where the Research Stands and What It Does Not Yet Tell Us

The evidence on saffron for AMD is encouraging but still preliminary. All of the human trials have been small, ranging from about 25 to 60 participants. None has been a large, multi-center randomized controlled trial, which is the kind of study that changes clinical practice. The longest follow-up to date is about 14 months, which is short for a condition that progresses over decades. And almost all of the strongest results come from early-stage AMD, where the disease has not yet caused severe vision loss.

For people with advanced dry AMD (geographic atrophy) or aggressive wet AMD already being treated with anti-VEGF injections, the data is thinner. No trial has shown that saffron can replace standard treatments for these stages. The more realistic framing, at least for now, is that saffron may serve as a complementary supplement alongside conventional care, not a replacement for it. A recent systematic review explicitly described saffron’s potential as an “adjunctive therapy” in ophthalmology rather than a standalone treatment.¹²

Practical Steps If You Decide to Try It

If you and your eye doctor agree that saffron supplementation is worth trying, here is what the evidence supports:

Dose: 20 mg per day of standardized saffron extract is the best-studied amount. Some trials used 30 mg. There is no evidence for going higher.
Form: A capsule containing standardized extract, not culinary saffron threads. Look for products that specify the crocin or crocetin content.
Timeline: Give it at least three months before evaluating whether it seems to be helping. Benefits in the trials appeared at the three-month mark.
Monitoring: Continue your regular eye exams. Saffron does not replace standard AMD monitoring, and you need objective measures like retinal imaging to track how your disease is actually progressing.
Ongoing use: The data suggests benefits require continuous supplementation. Stopping may cause the improvements to reverse.

Keep in mind that supplement quality varies widely. Saffron is one of the most frequently adulterated spices in the world, and the supplement market is no different. Third-party testing certifications can help, though they are not a guarantee. Buying from manufacturers that supply clinical trials or that have published certificates of analysis is one way to reduce the risk of getting a product that contains less than what the label claims.